Immunological antigen recognition

Immunological antigen recognition is the fundamental biological process by which the immune system identifies and distinguishes between self and non-self molecules. This process is primarily mediated by specialized receptors, including T-cell receptors (TCRs), B-cell receptors (BCRs), and various pattern recognition receptors (PRRs) such as Toll-like receptors [Janeway's Immunobiology, 9th Ed, 2016]. In the adaptive immune system, T cells recognize processed antigenic peptides presented on Major Histocompatibility Complex (MHC) molecules, a critical step for initiating specific immune responses [Nature Reviews Immunology, 2017]. This recognition event triggers intracellular signaling cascades that lead to lymphocyte activation, proliferation, and effector function. Dysregulation of this process is a hallmark of many diseases; for instance, the failure to recognize self correctly leads to autoimmune diseases, while the inability to recognize non-self or altered-self allows for chronic infections and tumor progression [Cellular and Molecular Immunology, 9th Ed, 2017]. Although Immunological antigen recognition is a complex physiological mechanism rather than a single molecular target, many therapeutic agents work by modulating specific components of this recognition machinery. For example, immune checkpoint inhibitors like pembrolizumab block inhibitory signals that prevent the recognition of tumor antigens, thereby enhancing the anti-tumor immune response [PubMed, PMID: 29335257].

Other names

Antigen recognitionImmune recognitionAntigen sensingAntigenic recognition

Modulation of the immunological synapse, inhibition of co-stimulatory or co-inhibitory signals, and interference with antigen-receptor binding.